CRC Featured Articles

1. The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research 7/31/2026

   Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.

2. The Renaissance Of Psychedelic Research: History, Protocols, And Forward Trajectories 7/30/2026

   Discover how clinical trial protocols are evolving to address unblinding, therapeutic support variables, and regulatory standards in modern psychedelic research.

3. Why Driving Impairment Evaluation Is Becoming More Important In CNS Drug Development 7/30/2026

   Vague warning labels leave patients and prescribers guessing about driving safety. Discover recent compliance data and learn how simulation studies clarify real-world functional risk.

4. 2026 Trends Shaping CNS Clinical Research 7/30/2026

   Central nervous system (CNS) trials are rapidly evolving. Learn how fit-for-purpose protocol design, centralized eligibility review, and novel modalities elevate clinical success.